Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of <i>Pseudomonas aeruginosa</i> Infection.

Martin, Isaac; Morales, Sandra; Alton, Eric W F W; Davies, Jane C

Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of Pseudomonas aeruginosa Infection.

Martin, Isaac; Morales, Sandra; Alton, Eric W F W; Davies, Jane C.

Affiliation

Martin I; National Heart and Lung Institute, Imperial College London, Emmanuel Kaye Building, London SW3 6LY, UK.
Morales S; Royal Brompton Hospital, Part of Guy's and St. Thomas' Trust, Sydney St., London SW3 6NP, UK.
Alton EWFW; Department of Paediatrics and Translational Medicine, The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada.
Davies JC; AmpliPhi Biosciences, Brookvale, NSW 2100, Australia.

Antibiotics (Basel) ; 12(3)2023 Mar 16.

Article in En | MEDLINE | ID: mdl-36978460

Key words

Pseudomonas aeruginosa; adjunctive therapy; antimicrobial resistance; bacteriophage; cystic fibrosis; novel antimicrobials; pulmonary infection

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Antibiotics (Basel) Year: 2023 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Antibiotics (Basel) Year: 2023 Type: Article Affiliation country: United kingdom